Revolution Medicines, Inc. (RVMD) Stock Analysis — Probabli.AI
AI-powered analysis for RVMD (Revolution Medicines, Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. AI consensus: Bullish.
Last price: $144.19 · Market cap: $31.8B · AI consensus: Bullish
Revolution Medicines appears to be in a strong position within the biotech sector, supported by a promising product pipeline, consensus bullish views, and positive clinical trial outcomes. While there are risks from competition, high cash burn, and equity issuance, the long-term growth story justifies a bullish stance.
Probabilistic 1-Year Outlook
- Bull 6000% · Neutral 3000% · Bear 1000%
- The company's recent progress in clinical trials and expansion in the oncology market is promising. Analysts are overwhelmingly positive about its short-term prospects, reflected by a strong buy consensus. However,…
5-Year Outlook
- Bull 7500% · Neutral 2000% · Bear 500%
SWOT Highlights
- Strength: Strong research and development pipeline
- Strength: Innovative oncology treatments
- Risk: Negative recent earnings surprises
- Risk: Volatility in stock performance
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
21 Wall Street analysts rate RVMD a STRONG BUY with a mean price target of $182.78.
Analysis generated Jun 11, 2026 · Model: gpt-4o. Run a fresh analysis on probabli.xyz/stock/RVMD.
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.